227939-01-7

Basic information

• Product Name: (5-BROMOPYRIDIN-2-YL)METHYL-CARBAMIC ACID TERT-BUTYL ESTER
• Synonyms: (5-BROMOPYRIDIN-2-YL)METHYL-CARBAMIC ACID TERT-BUTYL ESTER;2-(N-BOC-N-methylamino)-5-bromopyridine;N-Boc-N-methyl-5-bromo-2-pyridinamine;tert-Butyl (5-bromopyridin-2-yl)
• CAS NO: 227939-01-7
• Molecular Formula: C11H15BrN2O2
• Molecular Weight: 287.16
• Mol File: 227939-01-7.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 338.5°C at 760 mmHg
• Flash Point: 158.5°C
• Appearance: /
• Density: 1.391g/cm³
• Vapor Pressure: 9.8E-05mmHg at 25°C
• Refractive Index: 1.558
• Storage Temp.: 2-8°C
• CAS DataBase Reference: (5-BROMOPYRIDIN-2-YL)METHYL-CARBAMIC ACID TERT-BUTYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: (5-BROMOPYRIDIN-2-YL)METHYL-CARBAMIC ACID TERT-BUTYL ESTER(227939-01-7)
• EPA Substance Registry System: (5-BROMOPYRIDIN-2-YL)METHYL-CARBAMIC ACID TERT-BUTYL ESTER(227939-01-7)

Safety Data

• Hazardous Substances Data: 227939-01-7(Hazardous Substances Data)

Usage

General Description

(5-Bromopyridin-2-yl)methyl-carbamic acid tert-butyl ester is a chemical compound with the molecular formula C11H14BrN3O2. It is a carbamate ester, which is commonly used as a protective group for amines in organic synthesis. The presence of the bromine group makes this compound useful for various chemical reactions, including nucleophilic substitution and palladium-catalyzed coupling reactions. This chemical has potential applications in the pharmaceutical industry as a building block for the synthesis of biologically active compounds. Additionally, its tert-butyl ester group provides stability and protection for the reactive carbamate functionality, making it a valuable tool in organic chemistry.

InChI:InChI=1/C11H15BrN2O2/c1-11(2,3)16-10(15)14(4)9-6-5-8(12)7-13-9/h5-7H,1-4H3

Upstream product

• 84539-30-0 5-bromo-N-methylpyridin-2-amine 
• 24424-99-5 di-tert-butyl dicarbonate 
• 624-28-2 2,5-dibromopyridine 
• 74-88-4 methyl iodide 
• 159451-66-8 tert-butyl N-(5-bromopyridin-2-yl)carbamate 
• 1072-97-5 5-bromo-2-pyridylamine 

Downstream Products

• 1235449-52-1 N-hydroxy-2-(methyl((2-(6-(methylamino)pyridin-3-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)amino)pyrimidine-5-carboxamide 
• 1032758-87-4 methyl-[5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-pyridin-2-yl]-carbamic acid tert-butyl ester 

Relevant articles and documents

Diaromatic vinyl derivative as well as preparation method and application thereof

The structural formula of the diaromatic vinyl derivative is shown I. In-flight R1 Document CH3 (Methyl) or CD3 (Deuterated methyl). R2 A group selected from C1 - 8 saturated alkoxy or alkylamino, substituted C2

SELECTIVE INHIBITORS OF CLINICALLY IMPORTANT MUTANTS OF THE EGFR TYROSINE KINASE

The present invention provides compounds of Formula (I) or a subgeneric structure or species thereof, or a pharmaceutically acceptable salt, ester, solvate, and/or prodrug thereof, and methods and compositions for treating or ameliorating abnormal cell proliferative disorders, such as cancer, wherein A, R2, R3, R10, E1, E2, E3, Y, and Z are as defined herein.

THIAZOLOPYRIMIDINE PI3K INHIBITOR COMPOUNDS AND METHODS OF USE

Compounds of Formulas (Ia and Ib), and including stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, are useful for inhibiting lipid kinases including PI3K, and for treating disorders such as cancer mediated by lipid kinases. Methods of using compounds of formula Ia and Ib for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed